Page 153 - Syndipharma

Sobhan Oncology Pharmaceutical Co.

IRANIAN PHARMACEUTICAL COMPANIES DIRECTORY

Establishment: Year of 2010

Area of site plant: 25,000 sqm

Capital: 13,000,000 USD

Employees: 190 persons

Company Profile:
Sobhan Oncology Pharmaceutical Co. - is the leader in cancer treatment in IRAN located in Rasht Industrial City, that
had been constructed by Iranian specialists with sophisticated machinery under the supervision of M+W Process In-
dustries GmbH (formerly named LSMW) which is a pioneer in the field of site planning.
Sobhan Oncology Pharmaceutical Company, as a pioneer and innovator in the Iranian pharmaceutical industry, vowed
to fulfill the patients’ needs and to take care of their hopes to improve their health, protect their life and offer them
some innovative solutions. By further growing portfolio and strengthening the international presence, Sobhan On-
cology Pharmaceutical Co. will ensure that patients have greater access to a comprehensive range of vital quality
medicines at an affordable cost. We live to make patients’ dreams survive, Keeping Hope Alive.

Production Lines:
• Liquid dosage forms: Sterile injections, Lyophilized powder
• Solid dosage forms: Tablets and Capsules

Strengths:
First manufacturer of anti- cancer medicines in Iran.
Collaboration with the first class and novel manufacturers in the world for Under License production and Technology
Transfer
API resources from European approved suppliers
Sophisticated machinery
Under full supervision and qualification by licensor companies
Member of Barkat Pharmaceutical Holding Group and Alborz Investment Co. in IRAN

Premier Partners:
Roche (Switzerland), Sanofi (France), Stragen (Switzerland), Biosyn (Germany), Gedeon Richter (Hungary), Cipla
(India), Nippon Kayaku (Japan)

Certificates:
• GMP Certificates: Iran MOH, Tajikistan MOH, Iraq MOH, Uganda MOH
• Approved Satisfactory Audit by Sanofi (France) for Taxotere®20mg & 80mg
• Approved Satisfactory Audit by Roche (Switzerland) for packaging of MabThera®, Xeloda®, Pegasys®
• ISO10002:2014, ISO10004:2012, ISO9001:2008, ISO14001:2004
• OHSAS18001:2007

Target Countries for Exports:
• Selling Market: Syria, Iraq, Uganda, Tajikistan
• Under Registration: Kazakhstan, Sri Lanka,
• Future Target Market: Vietnam, The Philippines, Yemen, Jordan, CIS countries

152